pioglitazone has been researched along with cyclic gmp in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aminian, A; Dehpour, AR; Ejtemaeimehr, S; Javadi, S; Keyvanfar, HR; Mani, AR; Moghaddas, P; Rajabzadeh, A | 1 |
| Aliperti, LA; Gokce, A; Hagan, SS; Hellstrom, JA; Hellstrom, WJ; Kadowitz, PJ; Lasker, GF; Sikka, SC; Trost, LW | 1 |
| Peuler, JD; Phelps, LE | 1 |
3 other study(ies) available for pioglitazone and cyclic gmp
| Article | Year |
|---|---|
Pioglitazone potentiates development of morphine-dependence in mice: possible role of NO/cGMP pathway.
Topics: Animals; Cell Line, Tumor; Cyclic AMP; Cyclic GMP; Disease Models, Animal; Enzyme Inhibitors; Glioblastoma; Hippocampus; Humans; Hypoglycemic Agents; Male; Mice; Morphine Dependence; Naloxone; Narcotic Antagonists; Nitric Oxide; Nitric Oxide Synthase; Pioglitazone; PPAR gamma; RNA, Messenger; Signal Transduction; Substance Withdrawal Syndrome; Thiazolidinediones; Transfection | 2013 |
Efficacy of pioglitazone on erectile function recovery in a rat model of cavernous nerve injury.
Topics: Animals; Arterial Pressure; Cyclic GMP; Disease Models, Animal; Dose-Response Relationship, Drug; Erectile Dysfunction; Hemodynamics; Hypoglycemic Agents; Male; Microscopy, Fluorescence; Muscle, Smooth; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Penile Erection; Penis; Peripheral Nerve Injuries; Pioglitazone; Rats; Thiazolidinediones; Treatment Outcome | 2014 |
Sildenafil does not enhance but rather attenuates vasorelaxant effects of antidiabetic agents.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Antihypertensive Agents; Arteries; Cyclic GMP; Dose-Response Relationship, Drug; Drug Interactions; Glucose; Glycolysis; Hypoglycemic Agents; In Vitro Techniques; Metformin; Muscle, Smooth, Vascular; Nitric Oxide Donors; Nitroprusside; Phosphodiesterase 5 Inhibitors; Pioglitazone; Rats; Rosiglitazone; Sildenafil Citrate; Tail; Thiazolidinediones; Vasodilator Agents | 2015 |